Table 2 Clinical and conditions characteristics of patients infected with COVID-19
Clinical and conditions data | Total (n = 1063) | Survived (n = 589) | Deceased (n = 474) | P-value | |
|---|---|---|---|---|---|
Hospitalization, day | 3.02 ± 2.57 | 2.20 ± 1.63 | 4.05 ± 3.10 | < 0.001† | |
Admission type | Emergency | 561 (52.8%) | 266 (47.4%) | 295 (52.6%) | < 0.001‡ |
Urgent | 437 (41.1%) | 268 (61.3%) | 169 (38.7%) | ||
Elective | 65 (6.1%) | 55 (84.6%) | 10 (15.4%) | ||
No. of infection | Once | 756 (71.1%) | 423 (56.0%) | 333 (44.0%) | 0.673‡ |
Twice | 249 (23.4%) | 137 (55.0%) | 112 (45.0%) | ||
Three or more | 58 (5.5%) | 29 (50.0%) | 29 (50.0%) | ||
Family infection | Yes | 798 (75.1%) | 442 (55.4%) | 356 (44.6%) | 0.981‡ |
Travel | Yes | 451 (42.4%) | 270 (59.9%) | 181 (40.1%) | 0.012‡ |
Communication | Yes | 787 (74.0%) | 433 (55.0%) | 354 (45.0%) | 0.666‡ |
CPR case | Yes | 358 (33.7%) | 162 (45.3%) | 196 (54.7%) | < 0.001‡ |
Underlying conditions | Yes | 389 (36.6%) | 149 (38.3%) | 240 (61.7%) | < 0.001‡ |
Hyperlipidemia | Yes | 199 (18.7%) | 46 (23.1%) | 153 (76.9%) | < 0.001‡ |
Alcohol consumption | Yes | 16 (1.5%) | 2 (12.5%) | 14 (87.5%) | < 0.001‡ |
Transplantation | Yes | 20 (1.9%) | 6 (30.0%) | 14 (70.0%) | 0.021‡ |
Chemotropic | Yes | 14 (1.3%) | 3 (21.4%) | 11 (78.6%) | 0.010‡ |
Special Drugs | Yes | 8 (0.8%) | 0 (0.0%) | 8 (100%) | 0.002‡ |
Immunosuppressive Drugs | Yes | 40 (3.8%) | 12 (30.0%) | 28 (70.0%) | < 0.001‡ |
Pregnancy | Yes | 9 (0.8%) | 4 (44.4%) | 5 (55.6%) | 0.506‡ |
Smoking | Recently | 365 (34.3%) | 133 (36.4%) | 232 (63.6%) | < 0.001‡ |
Before | 174 (16.4%) | 97 (55.7%) | 77 (44.3%) | ||
Never | 524 (49.3%) | 359 (68.5%) | 165 (31.5%) | ||